| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b26fd5a13a0edf5d0c076173a610278e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3587105f62cd7b5dc2bbfbbb2757d537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ec9e25d493ac5f0b50922935e5d3555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_378140d6a63e31b9d703da29a75d720f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5147b68df46cb04ebc3cb79eda9016d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f705d310940013cb858c97a39b1cf2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8899bb3a906cbc420968956fdd22ac90 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-38 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2010-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95f00e2e62313fb5e141e66d3296003c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b891dde5c4c6fc16e174bf2f8026d98a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30581c4dd9487aacf51fb83c83a0d7c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bcb76ec1ab2e416d802106036538b73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89329f4122cac222dfbaeae0ed999112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7690a3bcf1433a6b1c273cb2d80635cb |
| publicationDate |
2010-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010101353-A2 |
| titleOfInvention |
Composition containing human serum albumin-timp-2 fusion protein and anti-cancer drug for preventing or treating cancer |
| abstract |
The present invention relates to a composition containing human serum albumin-TIMP-2-fusion protein and an anti-cancer drug for preventing or treating cancer. A group in which the composition is administered remarkably suppresses vasculogenesis and reduces tumor volume comparing to a group in which either the human serum albumin-TIMP-2 fusion protein or the anti-cancer drug is administered singly. Thus, the composition can be used for preventing or treating cancer due to the strong effect of suppressing cancer growth. |
| priorityDate |
2009-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |